Biotech company in Central Europe for sale

Company for sale

Sales: < 3 million EUR
Location: Central Europe
Reason for sale: A strategic partner or investor is being sought in order to exploit the international growth potential
#CFIE PHS151

Overview of biotech company in Central Europe for sale

An Austrian biotech company has developed a revolutionary platform product that is adept at performing a wide range of rapid medical tests. Now, it seeks a strategic partner or investor to help it expand its operations internationally. In addition, the company wants assistance to optimize its production process in order to further reduce the cost of each unit.

Subscribe as an interested buyer
Contact us to get details about this biotech company in Central Europe for sale

Profile (strategy) of biotech company in Central Europe for sale

Primarily, the company’s platform technology is based on a patented method that uses nanotechnology to create highly sensitive and specific sensors. Consequently, this allows the company to develop rapid tests for a wide range of medical applications.

Because the company’s platform technology is also highly scalable, this means that it can be used to produce large numbers of rapid tests at a relatively low cost. As a result, the company’s products are well-suited for use in resource-limited settings, such as developing countries. Most importantly, the company is already well-established in Austria and has a strong growth trajectory. Currently, it seeks a strategic partner or investor to help it expand its operations internationally. Moreover, the company desires assistance to optimize its production process in order to further reduce the cost of each unit.

Significantly, the company’s platform technology has the potential to revolutionize the way that medical tests are performed. Due to making rapid tests more accurate, affordable, and accessible, the company can help to improve the health of people around the world.

Curious about your company’s market value?
Use the link provided to access our valuation tool

Activities and products of biotech company in Central Europe for sale

This technological platform enables diverse, blood-based rapid tests to be processed decentrally with extraordinary accuracy

Highlights of biotech company in Central Europe for sale

Revolutionary platform technology capable of performing a wide range of rapid medical tests
Highly sensitive and specific sensors that allow for accurate and reliable results
Scalable platform able to produce large numbers of rapid tests at a relatively low cost
Well-established in Austria with a strong growth trajectory

More information on this biotech company in Central Europe for sale

Please get in touch if you are interested in learning more about this biotech company in Central Europe for sale. For more pharma companies for sale please visit the section pharma companies for sale. For other pharma buyers, please visit the section pharma companies wanted. If you are instead interested in pharma companies for sale, please visit the pharma companies for sale section. For pharma buyers, please visit the section pharma companies wanted.

Subscribe as an interested buyer for this Pharma company for sale

Please use a company e-mail address. No Hotmail/Yahoo/Googlemail etc.

Note: CFIE only works with formal companies. We do get a lot of requests and it is difficult to follow up on all inquiries from visitors to our website. For each company, we assess the likelihood of a future transaction. We only get back to you if we see a real opportunity to do a future acquisition or business sale. In order to increase your chances of receiving a reply as an individual, please explain as much as possible about your personal background, strategy, and fit with the target. There is also a possibility that your details will be kept on file, and we will get back to you once there is an opportunity to do a transaction. CFIE cannot guarantee you will receive an answer to your request.